OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The hypocretins/orexins: integrators of multiple physiological functions
Jingcheng Li, Zhian Hu, Luı́s de Lecea
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 332-350
Open Access | Times Cited: 229
Jingcheng Li, Zhian Hu, Luı́s de Lecea
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 332-350
Open Access | Times Cited: 229
Showing 1-25 of 229 citing articles:
Sleep, insomnia, and depression
Dieter Riemann, Lukas B. Krone, Katharina Wulff, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 1, pp. 74-89
Open Access | Times Cited: 586
Dieter Riemann, Lukas B. Krone, Katharina Wulff, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 1, pp. 74-89
Open Access | Times Cited: 586
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V. Mahler, David E. Moorman, Rachel J. Smith, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 10, pp. 1298-1303
Open Access | Times Cited: 358
Stephen V. Mahler, David E. Moorman, Rachel J. Smith, et al.
Nature Neuroscience (2014) Vol. 17, Iss. 10, pp. 1298-1303
Open Access | Times Cited: 358
The paraventricular thalamus is a critical thalamic area for wakefulness
Shuancheng Ren, Yaling Wang, Faguo Yue, et al.
Science (2018) Vol. 362, Iss. 6413, pp. 429-434
Open Access | Times Cited: 301
Shuancheng Ren, Yaling Wang, Faguo Yue, et al.
Science (2018) Vol. 362, Iss. 6413, pp. 429-434
Open Access | Times Cited: 301
Narcolepsy
Birgitte Rahbek Kornum, Stine Knudsen, Hanna M. Ollila, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 240
Birgitte Rahbek Kornum, Stine Knudsen, Hanna M. Ollila, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 240
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 204
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 204
Unraveling the Evolutionary Determinants of Sleep
William J. Joiner
Current Biology (2016) Vol. 26, Iss. 20, pp. R1073-R1087
Open Access | Times Cited: 202
William J. Joiner
Current Biology (2016) Vol. 26, Iss. 20, pp. R1073-R1087
Open Access | Times Cited: 202
Migraine and sleep disorders: a systematic review
Cindy Tiseo, Alessandro Vacca, Anton Felbush, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 185
Cindy Tiseo, Alessandro Vacca, Anton Felbush, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 185
A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 181
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 181
Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy
Roland Liblau, Anne Vassalli, Ali Seifinejad, et al.
The Lancet Neurology (2015) Vol. 14, Iss. 3, pp. 318-328
Closed Access | Times Cited: 177
Roland Liblau, Anne Vassalli, Ali Seifinejad, et al.
The Lancet Neurology (2015) Vol. 14, Iss. 3, pp. 318-328
Closed Access | Times Cited: 177
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 133
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 133
Orexin/hypocretin receptor signalling: a functional perspective
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 127
Christopher S. Leonard, Jyrki P. Kukkonen
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 294-313
Open Access | Times Cited: 127
The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
África Flores, Victòria Valls-Comamala, Giulia Costa, et al.
Neuropsychopharmacology (2014) Vol. 39, Iss. 12, pp. 2732-2741
Open Access | Times Cited: 119
África Flores, Victòria Valls-Comamala, Giulia Costa, et al.
Neuropsychopharmacology (2014) Vol. 39, Iss. 12, pp. 2732-2741
Open Access | Times Cited: 119
Sleep problems and their effect in ADHD
Roumen Kirov, Serge Brand
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 3, pp. 287-299
Closed Access | Times Cited: 117
Roumen Kirov, Serge Brand
Expert Review of Neurotherapeutics (2014) Vol. 14, Iss. 3, pp. 287-299
Closed Access | Times Cited: 117
The key role of insomnia and sleep loss in the dysregulation of multiple systems involved in mood disorders: A proposed model
Laura Palagini, Célyne Bastien, Donatella Marazziti, et al.
Journal of Sleep Research (2019) Vol. 28, Iss. 6
Open Access | Times Cited: 99
Laura Palagini, Célyne Bastien, Donatella Marazziti, et al.
Journal of Sleep Research (2019) Vol. 28, Iss. 6
Open Access | Times Cited: 99
A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects
Pascal Bonaventure, Sujin Yun, Philip L. Johnson, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 352, Iss. 3, pp. 590-601
Open Access | Times Cited: 94
Pascal Bonaventure, Sujin Yun, Philip L. Johnson, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 352, Iss. 3, pp. 590-601
Open Access | Times Cited: 94
Deconstructing arousal into wakeful, autonomic and affective varieties
Ajay B. Satpute, Philip A. Kragel, Lisa Feldman Barrett, et al.
Neuroscience Letters (2018) Vol. 693, pp. 19-28
Open Access | Times Cited: 94
Ajay B. Satpute, Philip A. Kragel, Lisa Feldman Barrett, et al.
Neuroscience Letters (2018) Vol. 693, pp. 19-28
Open Access | Times Cited: 94
Orexins and fear: implications for the treatment of anxiety disorders
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92
Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
Brain Research (2016) Vol. 1654, pp. 34-42
Open Access | Times Cited: 88
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
Brain Research (2016) Vol. 1654, pp. 34-42
Open Access | Times Cited: 88
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25
Laura Palagini, Pierre A. Geoffroy, Matteo Balestrieri, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 4
Closed Access | Times Cited: 25
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study
Rami Ben‐Joseph, Ragy Saad, Jed Black, et al.
SLEEP (2023) Vol. 46, Iss. 10
Open Access | Times Cited: 24
Rami Ben‐Joseph, Ragy Saad, Jed Black, et al.
SLEEP (2023) Vol. 46, Iss. 10
Open Access | Times Cited: 24
Inflammation-sleep interface in brain disease: TNF, insulin, orexin
Ian A. Clark, Bryce Vissel
Journal of Neuroinflammation (2014) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 86
Ian A. Clark, Bryce Vissel
Journal of Neuroinflammation (2014) Vol. 11, Iss. 1, pp. 51-51
Open Access | Times Cited: 86
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015)
Inder Pal Singh, Purvi Shah
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 1, pp. 17-36
Closed Access | Times Cited: 83
Inder Pal Singh, Purvi Shah
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 1, pp. 17-36
Closed Access | Times Cited: 83
The Deakin/Graeff hypothesis: Focus on serotonergic inhibition of panic
Evan D. Paul, Philip L. Johnson, Anantha Shekhar, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 379-396
Open Access | Times Cited: 80
Evan D. Paul, Philip L. Johnson, Anantha Shekhar, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 379-396
Open Access | Times Cited: 80
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
